Medical Policy and Clinical Guideline Updates – February 2020
February 10, 2020*GENE.00052 Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling – 5/1/2020
*CG-GENE-14 Gene Mutation Testing for Solid Tumor Cancer Susceptibility and Management – 2/5/2020
*CG-GENE-13 Genetic Testing for Inherited Diseases – 2/5/2020
*CG-GENE-20 Epidermal Growth Factor Receptor (EGFR) Testing – 2/5/2020
*CG-GENE-15 Genetic Testing for Lynch Syndrome, Familial Adenomatous Polyposis (FAP), Attenuated FAP and MYH-associated Polyposis – 2/5/2020
*CG-GENE-16 BRCA Testing for Breast and/or Ovarian Cancer Syndrome – 2/5/2020
*CG-GENE-17 RET Protooncogene Testing for Endocrine Gland Cancer Susceptibility – 2/5/2020
*CG-GENE-18 Genetic Testing for TP53 Mutations – 2/5/2020
*CG-GENE-19 Detection and Quantification of Tumor DNA Using Next Generation Sequencing in Lymphoid Cancers – 2/5/2020
CG-MED-87 Single Photon Emission Computed Tomography Scans for Noncardiovascular Indications – 2/5/2020
NOTE *Precertification required